Clinical Trial Update: Efficacy of Benefiber-Added, Reduced-Osmolarity WHO-ORS in the Treatment of Cholera in Adults [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the efficacy of Benefiber-added reduced-osmolarity WHO oral rehydration solution in adults with cholera.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholera

Drugs mentioned

• Benefiber-Added, Reduced-Osmolarity WHO-ORS

Snippet

Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh | Conditions: Cholera | Phase 2 | Status: COMPLETED